As part of our ongoing program directed to the identification of non-benzimidazole structurally related analogues to Enviroxime, we have recently reported that 2-amino-6-[(E)-l-phenyl-2-Nmethylcarbamoylvinyl]-imidazo[l,2-a]pyridines 6 can maintain the anti-rhinoviral activity found in benzimidazoles. In this new family the substitution at 3-position was a key element for activity and both isopropyl sulfenyl and aromatic tings were well tolerated.
Enviroxime I and related benzimidazoles 2'3 showed potent broad spectrum antiviral activity against a range of both rhinoviruses and enteroviruses. Noncytotoxic concentrations of Enviroxime are associated with complete inhibition of replication of 81 rhinovirus serotypes. However, studies of oral Enviroxime showed low levels in blood and nasal secretions and an unacceptably high frequency of nausea and vomiting: Thus, despite its potent in vitro anti-rhinovirus activity, significant therapeutic benefit was not found with either oral or intranasal administration, and Enviroxime clinical studies were terminated.
Despite this failure, considerable efforts are still devoted to the benzimidazole family with the aim of finding an antirhinoviral analogue with improved oral plasma levels and better safety profile:
As part of our ongoing program directed to the identification of non-benzimidazole structurally related analogues to Enviroxime, we have recently reported that 2-amino-6-[(E)-l-phenyl-2-Nmethylcarbamoylvinyl]-imidazo[l,2-a]pyridines 6 can maintain the anti-rhinoviral activity found in benzimidazoles. In this new family the substitution at 3-position was a key element for activity and both isopropyl sulfenyl and aromatic tings were well tolerated.
In a recent report, Spitzer et a/2'3 provided strong evidence for internal hydrogen bonding between the amine hydrogen and the sulfonyl oxygen which could account for the high potency exhibited by the Enviroxime. Acyl groups that would be expected to participate in the internal hydrogen-bond in an E-mail: hamdouchi_chafiq@lilly. flexibility. In the present case it made possible an investigation of the effect of acyl groups in a critical region of the molecule.
Our synthetic approach to the desired imidazo[1,2-a]pyridines envisioned incorporation of vinyl carboxamide followed by an alkylation with chloro or bromo ketones. The use of the one step procedure that we previously described for the generation of 2-aminoimidazo moiety from the corresponding 2-chloropyridinium salts (or ylides) would allow a direct access to our target structures. 7
To this end, compound 2, 8 was subjected to the Homer-Emmons reaction with diethyl(Nmethylcarbamoyimethyl)phosphonate, using KHMDS as a base in DMF, to give the key intermediate vinyl carboxamide 4 as 3:1 mixture of E and Z isomers. 9 The desired E-isomer 4 ]o was obtained in its pure form after a column chromatography. were required for the complete conversion. This conversion is notable in that it affords the desired 2-amino imidazo[1,2-a]pyridine derivatives in one-step, which is to our knowledge the shortest known method for the access to this type of nucleus.
The final imidazo[1,2-a]pyridines la-d were subjected to biological evaluation taking Enviroxime as a reference. Human rhinovirus-14 was selected as the routine and initial virus for testing due to the amount of information known about this serotype. The plaque reduction assays (PRA) were run in order to determine the antiviral activity IC50 and the cytopathic effect assays (CPE/XTr) were performed as described previously 11 in order to determine the general cellular toxicity TCs0 (Table 1) . Plaque reduction assay using HRV-14; Enviroxime used as reference (ICs0 = 0.045 Ixg/mL).
b CPE/XTT assay using HRV-14. c Dihedral angles, calculated with AM1 hamiltonian.
An acetyl group at 3-position afforded a compound with moderate antiviral activity. Interestingly t-butylacetyl at the same position provided a compound with an ICs0(~g/mL) of 0.17 in PRA assay, 15-fold more active than the methyl partner. A benzoyl substituent at C(3) also provided a potent compound.
A substitutent in para-position such as fluorine on the C(3) aryl was well-tolerated, providing a compound that maintained the activity. The biological data suggested that the antiviral activity is depending on the size of the group at C-3 and increases in the order methyl<aryl< t-butyl. However, the presence of an oxygen (C=O) that may participate in internal hydrogen bonding with the amine hydrogen does not seem to be critical to anti-rhinoviral activity as in the case of Enviroxime, 2 since the activity observed in the examples lb and lc is in the same order as that exhibited by their aryi partners. 6
In order to help understanding the role of the size of the group at C-3 on the activity, we carded out semi-empirical calculations. Compound la-d were studied using AM1 hamiltonian. The conformational profiles calculated for each structure exhibit minima that differ mostly in the dihedral angle around the carbonyl at C-3 (C2,C3,CO,O). The geometrical feature of this angle seems to correlate with the activity in this class of compounds. Higher dihedral angle in ld (45 °) afforded a compound with potent antirhinoviral activity. On the other hand compound la with very small dihedral angle (-1.7 °) didn't show significant activity.
Finally, compounds la-d were evaluated in a cytopathic effect assay in order to determine the general cellular toxicity TCs0. Compound ld seems to have quite high therapeutic index (ratio of TCs0 over ICs0 is higher than 60). In general no apparent cellular toxicity was observed in this series of compounds.
In summary, we have described an efficient approach to the synthesis of acyl substituted imidazo[ 1,2-a]pyridines, structurally related to Enviroxime. This study demonstrated that imidazopyridine nucleus not only maintains the anti-rhinoviral activity found in benzimidazole but also admits groups that are not tolerated in benzimidazoles. In the present case it allows to investigate the effect of acyl groups in a critical region of the molecule. Compounds lb, lc and ld exhibited strong anti-rhinoviral activity and no apparent cellular toxicity was found.
